F
Live / Allowed — Fifth extension granted (statement of use) (as of 26 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97676154
- Mark type
- Stylized text
- Filed
- 14 Nov 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of hyperuricemia and gout
Owner
- Teijin Pharma Limited, Chiyoda-ku, Tokyo, JP
- Teijin Pharma Limited, Chiyoda-ku, Tokyo, JP
Prosecution history
- 27 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jun 2026 — SOU EXTENSION 5 GRANTED
- 17 Feb 2026 — SOU EXTENSION 5 FILED
- 26 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2025 — SOU EXTENSION 4 GRANTED
- 31 Jul 2025 — SOU EXTENSION 4 FILED
- 31 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2025 — SOU EXTENSION 3 GRANTED
- 10 Feb 2025 — SOU EXTENSION 3 FILED
- 10 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2024 — SOU EXTENSION 2 GRANTED